NCT03075514View on ClinicalTrials.gov

Ketogenic Diets as an Adjuvant Therapy in Glioblastoma

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

March 5, 2019

Study Completion Date

March 5, 2019

Conditions
GlioblastomaGlioblastoma MultiformeGlioblastoma, Adult
Interventions
OTHER

MKD

Modified ketogenic diet

OTHER

MCT

Medium chain triglyceride ketogenic diet

Trial Locations (1)

L9 7LJ

Univeristy of Liverpool/ The Walton Centre NHS Foundation Trust, Liverpool

All Listed Sponsors
collaborator

Walton Centre NHS Foundation Trust

OTHER

collaborator

Vitaflo International, Ltd

INDUSTRY

lead

University of Liverpool

OTHER

NCT03075514 - Ketogenic Diets as an Adjuvant Therapy in Glioblastoma | Biotech Hunter | Biotech Hunter